Medtronic Halts Facility Shipments

Medtronic announced that its Physio-Control business has suspended U.S. shipments of external defibrillators and other products from its Redmond, WA-facility to address quality system issues raised by the company and regulators, the Associated Press reported.

The Minneapolis, MN-based heartbeat-regulating device manufacturer said both it and the FDA have identified quality issues at the facility, but Medtronic did not specify the issues.

Medtronic though said the suspension does not affect products currently in use worldwide.

Medtronic said the suspension should not have a material effect on earnings in the fiscal third quarter, which ends Jan. 26.